German mRNA giant Biontech reveals that the mRNA technology of the coronavirus vaccine could also be used in cancer, accelerating research, expecting to actually produce it by 2030.
Although advanced medical science This will allow us to invent vaccines and medicines. until making people in the present era live longer But there are still many diseases that have not been able to develop vaccines and drugs. one of them is “cancer”
According to the World Health Organization, cancer is one of the leading causes of death worldwide each year. That’s close to 10 million people in 2020, or nearly one in every six people will die from cancer, leading to breast cancer, lung cancer, colon cancer. and prostate cancer
However, recent medical advances in which an mRNA vaccine has been successfully invented in the fight against COVID-19 has raised hopes for development. “cancer vaccine” came up again that mRNA technology could be used to destroy cancer cells
Ugur Sahin and Dr. Ozlem Toureci The couple behind the COVID-19 vaccine Co-founder of BioNTech, a large German pharmaceutical company that has partnered with Pfizer to invent and produce an mRNA vaccine, told the BBC that a cancer vaccine could be developed. Really before the end of this decade or by 2030?
Both stated The process in mRNA technology, which is at the heart of the COVID-19 vaccine, could be used for another purpose. to prepare the immune system to attack cancer cells which the discovery of this advance That raises hopes that a cancer vaccine could be produced in the next few years. It is expected that it may be ready for use before 2030 (B.E. 2030).
The mRNA vaccine for the treatment of COVID-19 involves the delivery of genetic material, including the virus, into the human body. This allows the body to produce spike protein, which is the protein that stimulates the body’s immune system against the COVID-19 virus.
Dr. Touresi, who is also the chief medical officer at Biotech, said the same approach could also be used to prepare the immune system to find and destroy cancer cells. while biotech It was originally working on an mRNA cancer vaccine before the coronavirus pandemic. This caused the company to adjust to produce a vaccine instead of COVID.